Hyperprolactinemia associated with clinically silent adenomas: endocrinologic and pathologic studies; a report of two cases.
Pituitary adenomas containing adrenocorticotropic hormone (ACTH) in one case, and ACTH, beta-lipotropin, and beta-endorphin in the other, were demonstrated in two patients who had amenorrhea-galactorrhea and hyperprolactinemia with no manifestation of Cushing's disease. Neither adenoma contained prolactin (PRL). Initial bromocriptine therapy resulted in cessation of amenorrhea-galactorrhea and normalization of PRL levels. However, there was radiologic evidence of tumor enlargement in both patients. After pituitary adenomectomy, the two patients resumed regular menses and normal PRL dynamics. These patients illustrate the need for bromocriptine therapy for possible enlargement of their pituitary adenomas. The diagnosis of silent corticotroph adenoma should be kept in mind.
D000236:Adenoma / Q000032:analysis / Q000150:complications* / Q000648:ultrastructure; D000324:Adrenocorticotropic Hormone / Q000032:analysis; D000328:Adult; D004723:Endorphins / Q000032:analysis; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000209:etiology*; D010911:Pituitary Neoplasms / Q000032:analysis / Q000150:complications* / Q000648:ultrastructure; D001615:beta-Endorphin; D008083:beta-Lipotropin / Q000032:analysis
D004723:Endorphins; D001615:beta-Endorphin; D000324:Adrenocorticotropic Hormone; D008083:beta-Lipotropin